• Home
  • CorePharma, LLC.

CorePharma, LLC.

  • CorePharma - Regulatory Support Capabilities
  • CorePharma - cGMP Clinical Manufacturing
  • CorePharma - Commercial Manufacturing Capabilities
  • CorePharma - cGMP Clinical and Commercial Packaging
  • CorePharma - Preformulation and Formulation Capabilities
  • CorePharma - Analytical Development Capabilities
About CorePharma, LLC.

CorePharma, founded in 1998 and headquartered in Middlesex, NJ, is a leading pharmaceutical company specializing in contract development and manufacturing. We focus on producing oral solid dosage forms, utilizing our expertise and cutting-edge facilities covering over 150,000 square feet. With an annual production capacity of 5 billion units, adherence to cGMP standards, advanced technology, and a committed team, CorePharma delivers high-quality products that meet stringent regulatory requirements.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    United States
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
  • Website
  • 215 Wood Ave,,, 8846, Middlesex, NJ, United States
Show contact info Hide contact info
Meet us at

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia
2 Jun 2026 - 4 June 2026
View Exhibitor Profile

CorePharma, LLC. Resources (1)

  • News CorePharma Adds 2 Facilities, Expanding CDMO Capabilities

    CorePharma is expanding its development and manufacturing capacities with the incorporation of two new cGMP facilities, showcasing the NJ-based company’s rapid growth in the CDMO sector. The Pilot Scale Plant located on the same Middlesex campus is operational as of March 1st, while the second facility located in Edison, NJ will be operational in Q3 2025. 
    7 Mar 2025